BrainBase: a curated knowledgebase for brain diseases

Lin Liu(Chinese Academy of Sciences), Yang Zhang(Chinese Academy of Sciences), Guangyi Niu(Chinese Academy of Sciences), Qianpeng Li(Chinese Academy of Sciences), Li Zhao(Chinese Academy of Sciences), Tongtong Zhu(Chinese Academy of Sciences), Changrui Feng(Chinese Academy of Sciences), Xiaonan Liu(Chinese Academy of Sciences), Yuansheng Zhang(Chinese Academy of Sciences), Tianyi Xu(Chinese Academy of Sciences), Ruru Chen(Chinese Academy of Sciences), Xufei Teng(Chinese Academy of Sciences), Rongqin Zhang(Chinese Academy of Sciences), Dong Zou(Chinese Academy of Sciences), Lina Ma(Chinese Academy of Sciences), Zhang Zhang(Chinese Academy of Sciences)
Nucleic Acids Research
October 8, 2021
10.1093/nar/gkab987
Cited by 25Open Access
Full Text

Abstract

Brain is the central organ of the nervous system and any brain disease can seriously affect human health. Here we present BrainBase (https://ngdc.cncb.ac.cn/brainbase), a curated knowledgebase for brain diseases that aims to provide a whole picture of brain diseases and associated genes. Specifically, based on manual curation of 2768 published articles along with information retrieval from several public databases, BrainBase features comprehensive collection of 7175 disease-gene associations spanning a total of 123 brain diseases and linking with 5662 genes, 16 591 drug-target interactions covering 2118 drugs/chemicals and 623 genes, and five types of specific genes in light of expression specificity in brain tissue/regions/cerebrospinal fluid/cells. In addition, considering the severity of glioma among brain tumors, the current version of BrainBase incorporates 21 multi-omics datasets, presents molecular profiles across various samples/conditions and identifies four groups of glioma featured genes with potential clinical significance. Collectively, BrainBase integrates not only valuable curated disease-gene associations and drug-target interactions but also molecular profiles through multi-omics data analysis, accordingly bearing great promise to serve as a valuable knowledgebase for brain diseases.

Related Papers

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Yoav Benjamini, Yosef Hochberg|Journal of the Royal Statistical Society Series B (Statistical Methodology)|1995|108k
The Genotype-Tissue Expression (GTEx) project.
John T. Lonsdale|PubMed|2013|10k
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al.|New England Journal of Medicine|2005|7.2k
Guía de práctica clínica para el tratamiento de los tumores intracraneales
Danny Barrueta Reyes, Juan Guillermo Trigo Naranjo|Unknown|2009|5.3k
The Somatic Genomic Landscape of Glioblastoma
Cameron Brennan, Roel G.W. Verhaak, Aaron McKenna et al.|Cell|2013|5.1k